Results 151 to 160 of about 13,459 (185)

Corrigendum: Enhancing oncolytic virotherapy by extracellular vesicle mediated microRNA reprogramming of the tumour microenvironment. [PDF]

Front Immunol
Jennings VA, Rumbold-Hall R, Migneco G, Barr T, Reilly K, Ingram N, Hilare IS, Heaton S, Alzamel N, Jackson D, Ralph C, Banerjee S, McNeish I, Bell JC, Melcher AA, Ilkow C, Cook GP, Errington-Mais F.   +17 more
europepmc   +1 more source

Editorial: Advancements in feline oncology: diagnosis, treatment, and management of domestic cat cancers. [PDF]

Front Vet Sci
Horta RDS, Giuliano A, da Costa FVA.
europepmc   +1 more source

A Comprehensive Review of Modern Cancer Therapies Utilizing Oncolytic Viruses. [PDF]

Cells
Sułek M, Szuster-Ciesielska A.
europepmc   +1 more source

Oncolytic Virotherapy for Glioma: A Bibliometric Roadmap for Multidisciplinary Clinical and Research Strategies. [PDF]

J Multidiscip Healthc
Liu S, Liang R.
europepmc   +1 more source

Recurrent Glioblastoma and the Tumor Immune Landscape: Emerging Immunotherapeutic Strategies. [PDF]

Immunotargets Ther
Cao Z, Tong S, Wang Z, Ji C, Zhang C, Dai X, Wu B.   +6 more
europepmc   +1 more source

Oncolytic HSV-1 expressing GM-CSF and IL-12 enhances anti-tumor efficacy in immunocompetent murine melanoma model. [PDF]

Virol Sin
Xiao H, Yin Q, Liu J, Hu H, Li J, Wang M, Hu Z.   +6 more
europepmc   +1 more source

Oncolytic adenovirus encoding variant interleukin-2 combined with chemotherapy enables PD-L1 inhibition in pancreatic cancer models. [PDF]

Cancer Immunol Immunother
Pakola SA, Ojala N, Kudling TV, Clubb JHA, Jirovec E, van der Heijden M, Arias V, Haybout L, Basnet S, Grönberg-Vähä-Koskela S, Quixabeira DCA, Santos JM, Cervera-Carrascon V, Hemminki O, Kanerva A, Mustonen H, Puolakkainen P, Seppänen H, Hemminki A.   +18 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Oncolytic Virotherapy

2023
Oncolytic virotherapy opens up avenues for cancer treatment by selectively targeting the cancer cells and destructs them either through direct lysis or by inducing an immune response in the tumor microenvironment. This platform technology utilizes a diverse range naturally existing or genetically modified oncolytic viruses for their immunotherapeutic ...
Munazza, Fatima, Deeba, Amraiz, Muhammad Tariq, Navid   +2 more
openaire   +3 more sources